FDA Approval Activities for this Drug…

Tigan (Trimethobenzamide Hydrochloride) Suppositories, Injection, King NDA 17-529/S-009, 17-530/S-018 4/30/02 5/2/02 5/24/02 Tigan (Trimethobenzamide Hydrochloride) Capsules, King NDA 17-531/S-010 4/30/02 1/13/03 1/13/03 Tigan (Trimethobenzamide Hydrochloride) Capsules, 300 mg, King NDA 17-531 Trimethobenzamide Hydrochloride Capsules, 300mg Mutual Pharmaceutical ANDA 76-570 8/28/03 Trimethobenzamide Hydrochloride Capsules, 300mg Amide ANDA 76-546 TRIMETHOBENZAMIDE HYDROCHLORIDE Capsule; 300MG TRIMETHOBENZAMIDE HCL Amide 017531 TRIMETHOBENZAMIDE HYDROCHLORIDE Capsule; 300MG TIGAN KING 076570 TRIMETHOBENZAMIDE HYDROCHLORIDE Capsule; 300MG TRIMETHOBENZAMIDE HCL Mutual 088804 TRIMETHOBENZAMIDE HYDROCHLORIDE Injection 100MG/ML TRIMETHOBENZAMIDE HCL Abbott 017530 TRIMETHOBENZAMIDE HYDROCHLORIDE Injection 100MG/ML TIGAN KING

For the latest approval information, please locate this drug using this index.